Does chemo safety training boost job prospects

But i’m looking at formal USP <800> chemo handling and CSTD (Equashield/PhaSeal) training to transition into a specialty oncology team. For those already assisting with infusion days, did certification translate to better pay or a manageable 4x10 schedule, and did it give you more protected time for patient comfort checks and caregiver nausea and at-home care coaching?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌⁠‍‌‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​​​⁠​‍​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‌​‌‌‌⁠‌‍​‌‌‌​‌‌​‌⁠‌‌‍​‌​⁠‌‌‍⁠‌‌​​‌‌⁠​⁠​‍⁠‌‌‍⁠‍‌‌‍​‌⁠​⁠‌⁠​⁠‌‍​⁠​‍​‍‌⁠⁠‌​

USP <800> plus Equashield cert bumped my pay and got me a 4x10 only after I became our CSTD super-user and owned the competencies. > it give you more protected time for patient comfort checks and caregiver nausea and — I only got that when I put a 10‑min “HD counseling” block into the infusion template and coded it as hazardous-drug education so it couldn’t be bumped. Would your manager tie a small stipend/differential to a super-user role if you pitch it?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌⁠‍‌‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​​​⁠​‍​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌​‌​⁠⁠​⁠​‍‌​‌⁠‌​​‍‌‍‌‍‌⁠‌‌‌‍‍⁠​⁠‌‍​‍⁠‌‌​⁠⁠​⁠‌‌‌​‌⁠‌⁠​‍‌‌‍‌​⁠‌‍​‍​‍‌⁠⁠‌​​

Helped me, but the schedule gods still care about coverage — pair USP <800> + Equashield/PhaSeal with taking over spill drills and quarterly wipe sampling, then pitch a 4x10 that bakes in a 60‑min ‘comfort checks/teaching’ block. @mpatel16 is right on pay; mine only moved once I was tagged as the HD competency lead, so ask if they’ll sponsor the certs and put it in the staffing plan. Want a sample proposal I used?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍‌‌‌⁠‌​‌‍‌‌‌⁠​‍‌‍‍‌‌‍⁠‍‌‍​‌‌⁠​‍‌⁠‍‌‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​​​⁠​‍​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‌​⁠‌‍​‌‌‍​‌‌‍⁠​‌‍⁠​‌⁠​⁠‌​‌​‌‍⁠‌​⁠‌‌‌​⁠⁠​⁠​‌​⁠​⁠‌‌‌‌‌‍​‌​⁠​⁠​‍​‍‌⁠⁠‌​​